Current Ratio in % of Spyre Therapeutics, Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Spyre Therapeutics, Inc. quarterly Current Ratio history and change rate from Q3 2016 to Q3 2025.
  • Spyre Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 874 %, a 19.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 874 -217 -19.9% 30 Sep 2025
Q2 2025 806 -231 -22.3% 30 Jun 2025
Q1 2025 996 +633 +175% 31 Mar 2025
Q4 2024 1.11K +848 +328% 31 Dec 2024
Q3 2024 1.09K +910 +501% 30 Sep 2024
Q2 2024 1.04K +882 +571% 30 Jun 2024
Q1 2024 362 -107 -22.8% 31 Mar 2024
Q4 2023 259 -228 -46.9% 31 Dec 2023
Q3 2023 181 -319 -63.7% 30 Sep 2023
Q2 2023 155 -376 -70.8% 30 Jun 2023
Q1 2023 469 -77.2 -14.1% 31 Mar 2023
Q4 2022 486 -50.4 -9.39% 31 Dec 2022
Q3 2022 501 -115 -18.7% 30 Sep 2022
Q2 2022 530 -162 -23.4% 30 Jun 2022
Q1 2022 546 -222 -28.9% 31 Mar 2022
Q4 2021 537 -263 -32.9% 31 Dec 2021
Q3 2021 616 -46.2 -6.98% 30 Sep 2021
Q2 2021 692 +118 +20.6% 30 Jun 2021
Q1 2021 768 +250 +48.2% 31 Mar 2021
Q4 2020 800 +110 +16% 31 Dec 2020
Q3 2020 662 -143 -17.8% 30 Sep 2020
Q2 2020 574 -328 -36.3% 30 Jun 2020
Q1 2020 518 -469 -47.5% 31 Mar 2020
Q4 2019 689 -236 -25.5% 31 Dec 2019
Q3 2019 805 -204 -20.2% 30 Sep 2019
Q2 2019 901 -178 -16.5% 30 Jun 2019
Q1 2019 987 -122 -11% 31 Mar 2019
Q4 2018 925 -351 -27.5% 31 Dec 2018
Q3 2018 1.01K -457 -31.2% 30 Sep 2018
Q2 2018 1.08K -557 -34% 30 Jun 2018
Q1 2018 1.11K -711 -39.1% 31 Mar 2018
Q4 2017 1.28K -393 -23.6% 31 Dec 2017
Q3 2017 1.47K -174 -10.6% 30 Sep 2017
Q2 2017 1.64K 30 Jun 2017
Q1 2017 1.82K 31 Mar 2017
Q4 2016 1.67K 31 Dec 2016
Q3 2016 1.64K 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.